Boerman OC - Search Results

1

In vivo and in vitro characterizations of three 99mTc-labeled monoclonal antibody G250 preparations.

Steffens MG, Oosterwijk E, Kranenborg MH, Manders JM, Debruyne FM, Corstens FH, Boerman OC. Steffens MG, et al. Among authors: boerman oc. J Nucl Med. 1999 May;40(5):829-36. J Nucl Med. 1999. PMID: 10319758 Free article.

2

PET radioimmunoscintigraphy of renal cell cancer using 89Zr-labeled cG250 monoclonal antibody in nude rats.

Brouwers A, Verel I, Van Eerd J, Visser G, Steffens M, Oosterwijk E, Corstens F, Oyen W, Van Dongen G, Boerman O. Brouwers A, et al. Cancer Biother Radiopharm. 2004 Apr;19(2):155-63. doi: 10.1089/108497804323071922. Cancer Biother Radiopharm. 2004. PMID: 15186595 Free article.

3

Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studies.

Brouwers A, Mulders P, Oosterwijk E, Buijs W, Corstens F, Boerman O, Oyen W. Brouwers A, et al. Cancer Biother Radiopharm. 2004 Aug;19(4):466-77. doi: 10.1089/cbr.2004.19.466. Cancer Biother Radiopharm. 2004. PMID: 15453961

4

99mTc-HMPAO-labeled autologous versus heterologous leukocytes for imaging infection.

Gratz S, Rennen HJ, Boerman OC, Oyen WJ, Mast P, Behr TM, Corstens FH. Gratz S, et al. Among authors: boerman oc. J Nucl Med. 2002 Jul;43(7):918-24. J Nucl Med. 2002. PMID: 12097463 Free article.

5

Kinetics of 99mTc-labeled interleukin-8 in experimental inflammation and infection.

Rennen HJ, Boerman OC, Oyen WJ, Corstens FH. Rennen HJ, et al. Among authors: boerman oc. J Nucl Med. 2003 Sep;44(9):1502-9. J Nucl Med. 2003. PMID: 12960199 Free article.

6

Targeting of metastatic renal cell carcinoma with the chimeric monoclonal antibody G250 labeled with (131)I or (111)In: an intrapatient comparison.

Brouwers AH, Buijs WC, Oosterwijk E, Boerman OC, Mala C, De Mulder PH, Corstens FH, Mulders PF, Oyen WJ. Brouwers AH, et al. Among authors: boerman oc. Clin Cancer Res. 2003 Sep 1;9(10 Pt 2):3953S-60S. Clin Cancer Res. 2003. PMID: 14506194

7

Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.

Brouwers AH, van Eerd JE, Frielink C, Oosterwijk E, Oyen WJ, Corstens FH, Boerman OC. Brouwers AH, et al. Among authors: boerman oc. J Nucl Med. 2004 Feb;45(2):327-37. J Nucl Med. 2004. PMID: 14960657 Free article.

8

Pretargeting with bispecific anti-renal cell carcinoma x anti-DTPA(In) antibody in 3 RCC models.

van Schaijk FG, Oosterwijk E, Molkenboer-Kuenen JD, Soede AC, McBride BJ, Goldenberg DM, Oyen WJ, Corstens FH, Boerman OC. van Schaijk FG, et al. Among authors: boerman oc. J Nucl Med. 2005 Mar;46(3):495-501. J Nucl Med. 2005. PMID: 15750164 Free article.

9

Comparison of IgG and F(ab')2 fragments of bispecific anti-RCCxanti-DTIn-1 antibody for pretargeting purposes.

van Schaijk FG, Boerman OC, Soede AC, McBride WJ, Goldenberg DM, Corstens FH, Oosterwijk E. van Schaijk FG, et al. Among authors: boerman oc. Eur J Nucl Med Mol Imaging. 2005 Sep;32(9):1089-95. doi: 10.1007/s00259-005-1796-x. Epub 2005 May 18. Eur J Nucl Med Mol Imaging. 2005. PMID: 15902440

10

Residualizing iodine markedly improved tumor targeting using bispecific antibody-based pretargeting.

van Schaijk FG, Broekema M, Oosterwijk E, van Eerd JE, McBride BJ, Goldenberg DM, Corstens FH, Boerman OC. van Schaijk FG, et al. Among authors: boerman oc. J Nucl Med. 2005 Jun;46(6):1016-22. J Nucl Med. 2005. PMID: 15937314 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

500 results

Search Page

Filters